195 related articles for article (PubMed ID: 35636798)
1. Developing and validating a prognostic prediction model for patients with chronic kidney disease stages 3-5 based on disease conditions and intervention methods: a retrospective cohort study in China.
Zhang M; Lei N; Zhang XL; Xu Y; Chen HF; Fu LZ; Tang F; Liu X; Wu Y
BMJ Open; 2022 May; 12(5):e054989. PubMed ID: 35636798
[TBL] [Abstract][Full Text] [Related]
2. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
[TBL] [Abstract][Full Text] [Related]
3. A predictive model for progression of chronic kidney disease to kidney failure.
Tangri N; Stevens LA; Griffith J; Tighiouart H; Djurdjev O; Naimark D; Levin A; Levey AS
JAMA; 2011 Apr; 305(15):1553-9. PubMed ID: 21482743
[TBL] [Abstract][Full Text] [Related]
4. ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.
Hui M; Ma J; Yang H; Gao B; Wang F; Wang J; Lv J; Zhang L; Yang L; Zhao M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836039
[TBL] [Abstract][Full Text] [Related]
5. Self-management program for patients with chronic kidney disease (SMP-CKD) in Southern China: protocol for an ambispective cohort study.
Ouyang WW; Chen HF; Xu XY; Zhang XL; Fu LZ; Tang F; Wen ZH; Marrone G; Liu LC; Lin JX; Liu XS; Wu YF
BMC Nephrol; 2022 Mar; 23(1):93. PubMed ID: 35247988
[TBL] [Abstract][Full Text] [Related]
6. A Dynamic Predictive Model for Progression of CKD.
Tangri N; Inker LA; Hiebert B; Wong J; Naimark D; Kent D; Levey AS
Am J Kidney Dis; 2017 Apr; 69(4):514-520. PubMed ID: 27693260
[TBL] [Abstract][Full Text] [Related]
7. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
[TBL] [Abstract][Full Text] [Related]
8. Lipid parameters, adipose tissue distribution and prognosis prediction in chronic kidney Disease patients.
Chen HF; Xiao BJ; Chen LY; OuYang WW; Zhang XL; He ZR; Fu LZ; Tang F; Tang XN; Liu XS; Wu YF
Lipids Health Dis; 2024 Jan; 23(1):5. PubMed ID: 38185630
[TBL] [Abstract][Full Text] [Related]
9. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
11. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
[TBL] [Abstract][Full Text] [Related]
12. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
Ali I; Donne RL; Kalra PA
BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
[TBL] [Abstract][Full Text] [Related]
13. Validation of the kidney failure risk equation in European CKD patients.
Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
[TBL] [Abstract][Full Text] [Related]
14. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
16. Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.
James MT; Pannu N; Hemmelgarn BR; Austin PC; Tan Z; McArthur E; Manns BJ; Tonelli M; Wald R; Quinn RR; Ravani P; Garg AX
JAMA; 2017 Nov; 318(18):1787-1797. PubMed ID: 29136443
[TBL] [Abstract][Full Text] [Related]
17. Addition of the multidimensional prognostic index to the estimated glomerular filtration rate improves prediction of long-term all-cause mortality in older patients with chronic kidney disease.
Pilotto A; Sancarlo D; Aucella F; Fontana A; Addante F; Copetti M; Panza F; Strippoli GF; Ferrucci L
Rejuvenation Res; 2012 Feb; 15(1):82-8. PubMed ID: 22352434
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
19. Looking to the future: predicting renal replacement outcomes in a large community cohort with chronic kidney disease.
Marks A; Fluck N; Prescott GJ; Robertson L; Simpson WG; Cairns Smith W; Black C
Nephrol Dial Transplant; 2015 Sep; 30(9):1507-17. PubMed ID: 25943597
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
